Seeking Alpha

Seeking Alpha Portfolio App for iPad

LATEST ARTICLES

ARTICLES | NEWS | TRANSCRIPTS

Profiting From BARDA Contract Awards
Stock Investor • CBLI • Wed, May 22, 13:33 ET
Myriad Genetics: Disruptive Products For Cancer Diagnostics
David Zanoni • MYGN • Sun, May 19, 09:38 ET
Part 3: Will Array BioPharma Become A Late Stage Biopharmaceutical Company?
C.R. Jackson • ARRY • Thu, May 16, 01:00 ET
Myriad Genetics: Strong Results Ahead Of Supreme Court Decision
PSalerno • MYGN • Wed, May 15, 09:18 ET
Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock
Emerging Equities • AZN, NVS, ARRY • Wed, May 15, 05:45 ET
Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
C.R. Jackson • AMGN, AZN, CELG • Sun, May 12, 18:21 ET
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
C.R. Jackson • AMGN, AZN, EXEL • Sun, May 12, 18:06 ET
Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks
Scott Matusow • CMRX, CYTX, EBS • Tue, Apr 23, 09:31 ET
Acacia Research: A Conservative Investor's Choice For Investing In Intellectual Property
Mobile Guru • ACTG • Tue, Apr 23, 05:10 ET
Acacia Research's Earnings Were Terrible - And Why You Should Be Buying Now
Dustin Moore • ACTG • Mon, Apr 22, 13:41 ET
Myriad Genetics: Growth Stock, Hot Sector, Solid Industry
PSalerno • MYGN • Mon, Apr 22, 04:55 ET
Array's Up-Coming Value Enhancing Catalysts
Veziris Ventures • AMGN, AZN, NVS • Wed, Apr 17, 05:00 ET
These Stocks Profit From Innovation
StreetAuthority • VHC, IDCC, RMBS • Wed, Apr 10, 14:58 ET
Array BioPharma: An Exciting Year Ahead
BPD Research • ARRY • Thu, Mar 28, 16:14 ET
Piper Jaffray Likes Array, Should You?
Brian L. Wilson • ARRY • Mon, Mar 25, 16:40 ET
A $2.8 Billion Opportunity With All-Hazards Program: Will Cleveland Biolabs Get A Slice?
Austin Craig • SNGX.OB, AOLS.OB, CBLI • Tue, Mar 19, 15:31 ET
Risk/Reward For Shares Of Albany Molecular Are Balanced After A 300% Run Up In Shares
Paul Nouri • ACET, CBM, AMRI • Tue, Mar 19, 11:22 ET
Recent Weakness In Acacia Research Presents Buying Opportunity
LightseedVC • ACTG • Mon, Mar 4, 18:32 ET
Odyssey Marine: Full Of Surprises
Cliff-Fiscal • OMEX • Fri, Mar 1, 15:16 ET
Acacia Research: Risk And Reward Increase
Growth Stock Insider • ACTG • Tue, Feb 26, 15:29 ET
North Korea Tests A Nuke And This Anti-Radiation Stock Is Down?
Austin Craig • CBLI • Thu, Feb 14, 15:20 ET
IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe • IGXT.OB • Tue, Feb 5, 14:17 ET
Can Cleveland BioLabs Fight Radiation With This New Drug?
Austin Craig • CBLI • Mon, Feb 4, 10:24 ET
Acacia Research Corporation - Meeting Unmet Needs
Rochelle Jenks • ACTG • Fri, Jan 11, 06:56 ET
Aggressive Growth: Myriad Genetics
Zacks Investment Research • MYGN • Wed, Dec 19, 2012, 10:32 ET
Infinity Pharmaceuticals: Completion Of Phase I/II Trials May Drive Stock
LifeSci Advisors • INFI • Tue, Nov 27, 2012, 10:18 ET
Is Acacia Research Leading The Non-Practicing Entities?
Prescient Investment Analysis • ACTG • Mon, Nov 26, 2012, 16:22 ET
Odyssey Marine - Tying Up Black Swan's Loose Ends
David Kronenfeld • OMEX • Mon, Nov 19, 2012, 10:14 ET
Array BioPharma: A Diamond For The Long Term
Jorge Aura • ARRY • Thu, Oct 25, 2012, 14:49 ET
Load Up On Acacia Research Before This Stock Doubles
LightseedVC • ACTG • Thu, Oct 25, 2012, 11:36 ET
Cleveland Biolabs: Gunning For $50 Million In Government Funding
Austin Craig • QCOR, CBLI • Tue, Oct 23, 2012, 14:29 ET
Odyssey's Hidden Treasure: Chatham Rock Phosphate
Miles Williams • OMEX • Fri, Oct 12, 2012, 13:05 ET
Acacia Research Partners With Boston Scientific For A Major Medical Patent Play
Patrick Anderson • BSX, ACTG • Tue, Oct 9, 2012, 06:41 ET
Odyssey Marine Share Price Torpedoed
David Kronenfeld • OMEX • Tue, Sep 25, 2012, 16:48 ET
Cleveland BioLabs' Anti-Radiation Drug Makes It A Tempting Speculative Buy
Austin Craig • CBLI • Mon, Sep 17, 2012, 16:20 ET
Odyssey Marine - Ship Schedule; Stop Losses Still In Place
Bill Houseman • OMEX • Tue, Sep 11, 2012, 06:08 ET
Acacia Research Will Uniquely Benefit From Apple's Win, Has Approval From Samsung Too
Saul Rosenthal • ACTG • Thu, Sep 6, 2012, 07:50 ET
Odyssey Marine Has Sails Set
Bill Houseman • OMEX • Fri, Aug 24, 2012, 13:00 ET
Acacia CEO Paul Ryan Clarifies Second Quarter Results And 'Key Performance Metrics'
Patrick Anderson • ACTG • Mon, Aug 13, 2012, 09:14 ET
Investing In A 'Patent Troll' That Analysts Believe Will Double
Bret Jensen • AAPL, C, MSFT • Mon, Aug 6, 2012, 08:54 ET
A Tale Of 2 Quarters - Acacia Research Illustrates Patent Play Volatility
Patrick Anderson • ACTG • Wed, Aug 1, 2012, 08:12 ET
Can Array BioPharma's Breakout Run Hold Or Continue?
M. E. Garza • ARRY • Mon, Jul 23, 2012, 00:39 ET
Odyssey Marine Salvages Sunken Silver: What You Need To Know
Jared Sleeper • OMEX • Thu, Jul 19, 2012, 04:48 ET
Odyssey Marine: A Multi-Year Bull Market In The Making
LightseedVC • OMEX • Tue, Jul 10, 2012, 11:10 ET
IntelGenx Striving To Create A Second Biovail
Len Zehr • VRX, PRX, IGXT.OB • Tue, Jul 10, 2012, 10:07 ET
Treasure In The Sea: How To Invest
Jaded Consumer • OII, OMEX • Tue, Jul 3, 2012, 00:24 ET
AMRI Turnaround At Inflection Point
Len Zehr • AMRI • Wed, Jun 6, 2012, 16:00 ET
Albany Molecular Turnaround Provides Investment Opportunity
Paul Nouri • BMY, AMRI • Fri, Jun 1, 2012, 16:27 ET
Odyssey Marine Exploration: Top Reasons To Be Long
LightseedVC • GS, OMEX • Thu, May 24, 2012, 07:33 ET
Acacia Research: Still The Game Changer
Growth Stock Insider • ACTG • Wed, May 23, 2012, 12:22 ET

First Page
Previous Page
1 - 50 of 123
Next Page
Last Page